$利安-华侨证券恒生科技ETF(S$)(HST.SG)$ Shares of Fosun International 0656.HK fall 2.1% to HK$4.20, biggest pct loser in Hang Seng Composite Index on conglomerates .HSCIC ** Fosun isopen to selling its remaining stake in Portugal's Millennium bcp BCP.LS, two sources familiar with the matter told Reuters ** The company has been evaluating options, such as finding a strategic buyer for the 20% holding, one of the sources said ...
Fosun International's moderate P/S ratio alongside slower revenue growth hints at an overly optimistic market sentiment. Such a sentiment might expose shareholders to disappointment and potential share price decrease.
The company's liabilities significantly overshadows its cash and short-term receivables, indicating a potential need for a significant recapitalization if creditors were to demand repayment. The lack of profitability, significant EBIT loss and sizeable liabilities make Fosun International a risky investment.
According to the news,$復星國際(00656.HK)$has appointed a financial consultant to sell less than 5% of its shares in Cainiao. The plan is still in the preliminary stage. It is reported that Fosun, which once owned 6.7% of Cainiao's shares in 2020, has negotiated with potential buyers including Alibaba about its shares in this logistics company, because the company ne...
Picture this: a conglomerate that has stakes in Club Med, Cirque du Soleil, Thomas Cook and Wolverhampton Wanderers Football Club. You might have thought that this is a European company. But no. It is Fosun International, a Chinese conglomerate that is listed in Hong Kong under the ticker 656. Besides these European names, Fosun has investments that span many industries - banking, entertainment, fashion, F&B, hospitals, real estate, tourism and more. Some well k...
復星國際郭廣昌:新冠mRNA疫苗復必泰審批進展正常,在程序方面公正透明。CDE(國家藥品監督管理局藥品審評中心)和藥監局給了復星很大的支持。 復星醫藥A股、港股盤中直線拉升,均一度漲5%。 Fosun says China's review of BioNTech shots proceeds normally. Shares of Shanghai Fosun Pharmaceutical climb 4.58% in Shanghai at the morning close. Shanghai Fosun Pharmaceutical rises 6.72% at the morning close in HongKong. $復星國際(00656.HK)$ $復星醫葯(600196.SH)$ $復星醫藥(02196.HK)$
FOSUN INTL.ADR股票討論區
Shares of Fosun International 0656.HK fall 2.1% to HK$4.20, biggest pct loser in Hang Seng Composite Index on conglomerates .HSCIC
** Fosun isopen to selling its remaining stake in Portugal's Millennium bcp BCP.LS, two sources familiar with the matter told Reuters
** The company has been evaluating options, such as finding a strategic buyer for the 20% holding, one of the sources said
...
It is reported that Fosun, which once owned 6.7% of Cainiao's shares in 2020, has negotiated with potential buyers including Alibaba about its shares in this logistics company, because the company ne...
You might have thought that this is a European company.
But no. It is Fosun International, a Chinese conglomerate that is listed in Hong Kong under the ticker 656.
Besides these European names, Fosun has investments that span many industries - banking, entertainment, fashion, F&B, hospitals, real estate, tourism and more.
Some well k...
$藥品(BK1067.HK)$
$復星國際(00656.HK)$
$開拓藥業-B(09939.HK)$
$藥品(BK1067.HK)$
$復星國際(00656.HK)$
$開拓藥業-B(09939.HK)$
復星醫藥A股、港股盤中直線拉升,均一度漲5%。
Fosun says China's review of BioNTech shots proceeds normally.
Shares of Shanghai Fosun Pharmaceutical climb 4.58% in Shanghai at the morning close.
Shanghai Fosun Pharmaceutical rises 6.72% at the morning close in HongKong.
$復星國際(00656.HK)$
$復星醫葯(600196.SH)$
$復星醫藥(02196.HK)$
$復星醫藥(02196.HK)$
$復星國際(00656.HK)$
$贛鋒鋰業(01772.HK)$
$摩根大通(JPM.US)$
$生物疫苗(BK0475.SH)$
$復星國際(00656.HK)$
$復星醫藥(02196.HK)$
$復星醫葯(600196.SH)$
暫無評論